共 50 条
- [41] Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy: Results of a Prospective Single-Center Trial JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 534 - 534
- [44] Selective Implementation of Belatacept (Bela) Every Other Month as a Standard Care Option with the Use of Donor-Derived Cell-Free DNA (dd-cfDNA) Testing JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):